L’ulcère du pied diabétique: L’oxygénothérapie
hyperbare dans le traitement des ulcères réfractaires /
The Diabetic Foot Ulcer: Hyperbaric Oxygen Therapy in the Treatment of
Refractory Ulcers
Par/By Richard Belley et François Paquet
Références/References
1. Harris et al. Type 2 diabetes in family practice: Room for improvement.
Canadian Family Physician. 2003;49:778-785.
2. Bowker JH, Pfeifer MA. Levin and O’Neal’s The Diabetic
Foot, Sixth Edition. Moseby. 2001: 345-51.
3. Krasner DL, Rodeheaver GT, Sibbald RG. Chronic Wound Care: A Clinical
Source Book for Healthcare Professionals, Third Edition. HMP Communications.
2001.
4. Han P, Ezquerro R. Diabetic foot wound care algorithms. J. Amer.
Podiatric Med. Assoc. 2002;92(6):336-349.
5. Foot care: Canadian Diabetes Association 2003 clinical practice guidelines
for the prevention and management of diabetes in Canada. Canadian Journal
of Diabetes. 2003:27(supple. 2).
6. Ulbrecht JS, Cavanagh PR, Caputo GM. Foot problems in diabetes: An
overview. Clinical Iinfectious Diseases. 2004;39:S73–82.
7. Muller et al. Foot ulceration and lower limb amputation in type 2 diabetic
patients in Dutch primary health care. Diabetes Care. 2002;25:570-574.
8. Ramsey et al. Incidence, outcomes and cost of foot ulcers in patients
with diabetes. Diabetes Care. 1999;22:382-387.
9. Clinical guidelines for type 2 diabetes: Prevention and management
of foot problems. University of Sheffield in collaboration with the Royal
College of General Practitioners on behalf of the National Institute of
Clinical Excellence, United Kingdom, draft for second consultation, August
2003.
10. Viswanathan V et al. Effectiveness of different types of footwear
insoles for the diabetic neuropathic foot. Diabetes Care. 2004;
27(2):474-77.
11. Ortegon MM et al. Cost effectiveness of prevention and treatment of
the diabetic foot. Diabetes Care. 2004;27:901-907.
12. Zimmy S et al. The role of limited joint mobility in diabetic patients
with an at risk foot. Diabetes Care. 2004;27:942-946.
13. Belley R. Un concept régional de Clinique du Pied Diabétique:
Implantation d’un modèle sur une base locale pour une meilleure
prévention des complications microvasculaires dans la région
Chaudière Appalaches, janvier 2004. Disponible sur demande à
l’auteur richard_belley@ssss.gouv.q.ca
14. Armstrong DG, Lavery LA, LB Harkless Validation of a diabetic wound
classification system. The contribution of depth, infection, and ischemia
to risk of amputation. Diabetes Care. Vol. 21:855-859. -
15. Wyss CA, Matsen FA III, Simmons CW, et al. Transcutaneous oxygen measurements
on limbs of diabetic and nondiabetic patients with peripheral vascular
disease. Surgery. 1984;95:339-345.
16. Bunt TJ, Holloway GA. TcPO2 [should this be TcPO2?] as an accurate
predictor of therapy in limb salvage. Ann Vasc Surg. 1996;10(3):
224-7.
17. Cianci P, Sato R. Adjunctive hyperbaric oxygen therapy in the treatment
of thermal burns: A review. Burns. 1994.20(1):5-14.
18. Reiber GE, RE Pecoraro, Koepsell TD. Risk factors for amputation in
patients with diabetes mellitus. A case-control study. Ann Intern Med.
1992;117(2):97-105.
19. Medicare Review Policy No.98A-0016-L. Medicare Part A Medical Policy.
1998.
20. White RA, Klein SR. Amputation level selection by transcutaneous oxygen
pressure determination. In Moore WS, Malone JM, (eds.). Lower Extremity
Amputation. Philadelphia, PA: WB Saunders. 1989:44-49.
21. Wyss CR, Harrington RM, Burgess EM, et al. Transcutaneous oxygen tension
as a predictor of success after an amputation. J Bone Jt Surg.
1988;70-A:203-207.
22. Sheffield PJ. Measuring tissue oxygen tension: A review. Undersea
Hyperb Med. 1998;25(3):179-188.
23. Sheffiled PJ. Tissue oxygen measurements. In JC Davis, TK Hunt (eds.).
Problem Wounds: The Role of Qxygen. New York: Elsevier. 1988:1751.
24. White RA, et al. Noninvasive evaluation of peripheral vascular disease
using transcutaneous oxygen tension. Am J Surg. 1982;144(1):68-75
25. Kang TS, Gorti GK, Quan SY, Ho M, Koch RJ. Effects of hyperbaric oxygen
on the growth factor profile of fibroblasts. Arch Facial Plast Surg.
2004;6(1):31-5.
26. Cianci P, Petrone G, Drager SW, et al. Salvage of the problem wound
and potential amputation with wound care and adjunctive hyperbaric oxygen
therapy: An economic analysis. J Hyperbaric Med. 1988;3:127.
27. Cianci P. Adjunctive hyperbaric oxygen therapy in the treatment of
the diabetic foot. JAPMA. 1994;84:448.
28. Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric
oxygen therapy in the treatment of diabetic foot ulcer. A randomized study.
Diabetes Care. 1996;19:1338-43.
29. Kalani M, Jorneskog G, et al. Hyperbaric oxygen (HBO) therapy in the
treatment of diabetic foot ulcers. Long-term follow-up. Journal of
Diabetes and its Complications. 2002;16:153-158.
30. Baroni G, Porro T, Faglia E, et al. Hyperbaric oxygen in diabetic
gangrene treatment. Diabetes Care. 1987;10(1)81-86.
31. Davis JC. The use of adjuvant hyperbaric oxygen in treatment of the
diabetic foot. Clinics in Podiatric Medicine and Surgery. 1987;4(2):429-43
32. Hammarlund C, Sundberg T. Hyperbaric oxygen reduced size of chronic
leg ulcers: a randomized double-blind study. Plast Reconstr Surg.
1994;93:829-33.
|
|
|
